Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2010

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present a corporate overview at the following investment conferences:

• Deutsche Bank's 35th Annual Health Care Conference at the InterContinental Hotel in Boston on Tuesday, May 4, 2010 at 3:30pm Eastern Time (12:30pm Pacific Time)
• JMP Securities 9th Annual Securities Research Conference at the Palace Hotel in San Francisco on Monday, May 10, 2010 at 11:30am Eastern Time (8:30am Pacific Time)
• Bank of America Merrill Lynch 2010 Health Care Conference at the Grand Hyatt Hotel in New York City on Wednesday, May 12, 2010 at 10:00am Eastern Time (7:00am Pacific Time)

Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com. To access the presentations, click on the Investor Relations tab the link entitled "Events and Presentations" on the left side of the screen.  A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.

SOURCE Cadence Pharmaceuticals, Inc.